In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD,

Slides:



Advertisements
Similar presentations
Coagulopathy and blood component transfusion in trauma
Advertisements

Blunt trauma patient intubated in field, has decreased breath sounds on left, hemodynamically stable, sat 96% Next move: A) advance ET tube B) needle thoracostomy.
Permissive Hypotension By Joseph Lewis, M.D. Medical Director, Honolulu Emergency Services Division May, 2012.
FLUID RESUSCITATION TRAUMA PATIENT Author; Prof.MEHDI HASAN MUMTAZ Consultant Intensivist/ Anaesthetist Christie Hospital,Manchester,U.K.
Limmer et al., Emergency Care Update, 10th Edition © 2007 by Pearson Education, Inc. Upper Saddle River, NJ CHAPTER 30 Putting It All Together for the.
Cardiopulmonary Arrest
Trauma Associated Severe Hemorrhage (TASH)-Score: Probability of Mass Transfusion as Surrogate for Life Threatening Hemorrhage after Multiple Trauma The.
Uncontrolled Hemorrhagic Trauma: When all else fail to stop Mohamed Saleh, MD Department of Anesthesia and Intensive Care, Ain-Shams University.
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Massive transfusion: New Protocol
Massive Transfusion in the New Era
Mm Hypotensive resuscitation FROm animal study to clinical practice Dr YW Wong United Christian Hospital.
TXA in trauma patients: who should we treat and when?
Tranexamic acid safely reduces mortality in bleeding trauma patients Here we present the evidence.
Advanced Trauma Life Support (ATLS): 8 th edition-Changes of Importance to Anesthesiologists Journal Club October 2009 Hiral Patel, D.O.
Transfusion Management of massive haemorrhage in children Ongoing severe bleeding (overt / covert) and received 20ml/kg of red cells or 40ml/kg of any.
Blood Components Dosage And Their Administration
1 5/8/2015 Seven Day Storage At 4°C Of Previously -80°C Frozen AB Plasma Sm. Remco Strelitski, BSc Chief Lab technician, Military Blood Bank, Netherlands.
Prehospital Air Medical Plasma (PAMPer) Trial TACTIC at AAST September 9th.
Pragmatic, Randomized Optimal Platelet and Plasma Ratios
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-
Yaniv Berliner. Scene survey  EMS must first evaluate the safety of the scene.  Downed power lines, fire, traffic  Is there a need for specialized.
Prehospital Use of Plasma for Traumatic Hemorrhage (PUPTH Study) Community Disclosure.
FLUID RESUSCITATION CURRENT THINKING Dr Sean R Santos CGH.
Senior clinician Request: a o 4 units RBC o 2 units FFP Consider: a o 1 adult therapeutic dose platelets o tranexamic acid in trauma patients Include:
Lactated Ringer’s is Superior to Normal Saline in the Resuscitation of Uncontrolled Hemorrhagic Shock Presented by intern 陳姝蓉 S. Rob Todd, MD et al, Journal.
Tranexamic Acid (TXA) Trial Study
Transfusion Management of Massive Haemorrhage in Adults Patient bleeding / collapses Ongoing severe bleeding eg: 150 mls/min and Clinical shock Administer.
Jamaica Conference 3/30/15 Sariah Khormaee TRANEXAMIC ACID (TXA): The promise of a nearly perfect drug for the bleeding trauma patient.
Issues in Trauma Lynne Fulton May 27, Intro No basics My backround “Demanded efficient and thoughful care by other team members” Observing a patient.
A Patients Survival Story Dr Laura Attwood EM Consultant, RVI Pre Hospital Care Consultant, GNAAS.
Hemorraghic Shock Sara Parker MD VCU Trauma Conference STICU Fellow
Update on Hemostatic Resuscitation RAHUL J ANAND MOLLY FLANNAGAN DIVISION OF TRAUMA, CRITICAL CARE, AND EMERGENCY GENERAL SURGERY.
French army 2009 update of transfusion policy in military overseas operations S. Ausset 1, E. Meaudre 2, E. Kaiser 2, B. Clavier 3, P. Gerome 4, A.V. Deshayes.
University of Texas Southwestern Resuscitation Research Projects University of Texas Southwestern Resuscitation Research Projects.
Intern 謝旻翰. Introduction (I) Benefit –Volume restoration, improved O2 carrying capacity Risk –Transfusion reaction, blood-bore pathogen, limited supply,
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Presented by Intern Huang, Yu-Hao
Irina Vasilyeva, Moscow, Russia Russian National Research Medical University Clinical and Research Institute of Emergency Children’s Surgery and Trauma.
Tranexamic Acid in Trauma Kids Too?
Applying CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) in a Pre- Hospital Wilderness Context Paul B. Jones PGY1.
IR for Trauma & Trauma Networks Professor Keith Willett Working in partnership with.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
Tranexamic Acid: A Cost Effective Medication to Decrease Death From Acute Blood Loss in Trauma Patients Brandon M. Smith Pacific University School of Physician.
James Regan Trauma M&M. Situation Admitting Dx: MVC Procedure: Resuscitative thoracotomy, exploratory laparotomy Complication: Death.
THE STTTOPPP The bleeding randoMiZed controlled trial
Fluid Resuscitation for Hemorrhagic Shock in TCCC
Evaluation of the capacity of the trauma induced coagulopathy clinical score (ticcs) TO identify trauma patients presenting early acute coagulopathy evaluated.
“Running with the Bulls” Massive Transfusion in the ED
THE TRAUMA INDUCED COAGULOPATHY CLINICAL SCORE: A TOOL FOR SEVERE TRAUMA PATIENTS MANAGEMENT Tonglet M, Minon JM, Vergnion M, CHR de la Citadelle, LIEGE,
Warfarin Toxicity Treatment & Management
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Martin Tonglet, Liège University Hospital
Continued Scene Assessment
CRASH 2 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2):
How I treat patients with massive hemorrhage
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Michael S. Blanc, FACC, FSCAI Medical Director
Tranexamic acid safely reduces mortality in bleeding trauma patients
Damage Control Resuscitation: for Abdominal and Pelvic Injury
RETROSPECTIVE ANALYSIS OF MASSIVE TRANSFUSION PRACTICE IN NON-TRAUMA RELATED HEMORRHAGIC SHOCK IN A TERTIARY CARE CENTRE Dr. Gayathri.A.M, Dr.S.Sathyabhama,
Journal Club October 2009 Hiral Patel, D.O.
Tranexamic acid safely reduces mortality in bleeding trauma patients
Trauma Resuscitations, Past, Present and Future Practices
The epidemiology and management of haemorrhagic complications in patients with advanced haematological malignancies followed at home C. Cartoni (2),
Tranexamic Acid (TXA) Procedure #706 – Hemorrhage Control
Blood Components Dosage And Their Administration
Tranexamic Acid (TXA) Procedure #706 – Hemorrhage Control
Perspectives on Revised European Guidelines on Management of Bleeding and Coagulopathy Following Major Trauma.
Presentation transcript:

In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD

Danish Air Ambulance/HEMS Denmark In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Danish Air Ambulance/HEMS Denmark Three bases in Skive, Billund and Ringsted 3-crew concept: DOC, pilot, HEMS Crew member Airbus EC-135 P2+ VFR/IFR/NVG/PINS 24/7/365 In average 3 mission/base/day 2 RBC and 2 plasma on board

Severe blunt truncal injuries, male 24 yrs old In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report x 24  Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Severe blunt truncal injuries, male 24 yrs old Remote location, 104 NM distance, fuel considerations/options Damage Control Rescuscitation initiated before HEMS arrival FAST & X-rays: massive bleeding, multiple injuries, pelvic fracture, head trauma 2 chest tubes, pelvic sling, multiple IV lines, CVC, a-line Medical ambition: Transfer to Level 1 Trauma Centre

In-flight, 50 mins flying time: 7 RBC 4 plasma 1 l Albumin In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Before HEMS take-off: 5 RBC 2 l Albumin 3,5 l crystalloid TXA 2 g In-flight, 50 mins flying time: 7 RBC 4 plasma 1 l Albumin 2,5 l crystalloid 2 pressure perfusors Golden Hour Container SBT 60-80 Spontaneous breathing on ET tube, ETCO2 5.0-6-0, RF 8-10/min S-Ketamine, Fentayl, Noradrenalin 0.20-0.50 microg/kg/min

2 platelet concentrates (4 donors) TXA 2 g In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD In Trauma Centre: 13 RBC 13 plasma 2 platelet concentrates (4 donors) TXA 2 g Damage Control laparotomy/thoracotomy Injuries were deemed unsurvivable and further treatment futile

On arrival in Trauma Centre: Coagulopathy: INR 1,7 In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD On arrival in Trauma Centre: Coagulopathy: INR 1,7 TEG: decreased platelet/fibrinogen function

Massive in-flight rescuscitation of blood products is feasible In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Conclusions: Massive in-flight rescuscitation of blood products is feasible Damage Control Rescuscitation aiming at 1:1:1 of RBC, plasma and platelets should be prioritized to avoid dilution and further coagulopathy On-board blood products optimally shoud consist of all three since local hospital transfusion support is scarce

2. Effect of plasma in prehospital phase – Randomized Controlled Trial In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Discussion: Feasiblility of prehospital Damage Control Rescuscitation is demonstrated How can we improve: 1. Platelet function: evaluation in the prehospital phase and on arrival in hospital. 2. Effect of plasma in prehospital phase – Randomized Controlled Trial 3. Effect of prehospital platelet transfusion – Randomized Controlled Trial

Recent/current studies on the way: In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Discussion: Recent/current studies on the way: PATCH TRIAL – TXA study from Australia. Recap of CRASH2 but starting in the prehospital phase Prehospital Administration of Tranexamic Acid i Trauma Patients Crit Care 2016 20:143. Wafaisade et al. Significantly improved early survival , prolonged time to death, the more injured, the better the effect of TXA, recommends first dose of TXA en route to hospital

Recent/current studies on the way: In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD Discussion: Recent/current studies on the way: RePHILL – Resuscitation with Prehospital Blood Products Randomization between crystalloid 1 l 0.9% saline or 2 RBCs + 2 Plasma to traumatic injury resulting in hemorrhage HEMS setting in Austria very similar to Danish Air Ambulance/HEMS Denmark Fibrinogen concentrate in trauma patients, presumed to bleed Fries et al Severely traumatized patients with visible significant and/orclinical signs of severe bleeding are randomized to either placebo or Fibrinogen according to weight. HEMS/Physician Manned Ambulance setting in Austria and Germany

In-flight Damage Control Resuscitation of massive bleeding – challenges and opportunities during long flights. A Case Report   Peter Martin Hansen, MD, Jakob Stensballe, MD, PhD THANK YOU – FLY SAFE